首页 > 最新文献

International journal of physiology, pathophysiology and pharmacology最新文献

英文 中文
Early consumption of high-fat diet worsens renal damage in spontaneously hypertensive rats in adulthood. 早期食用高脂肪食物会加重成年期自发性高血压大鼠的肾损害。
Pub Date : 2019-12-15 eCollection Date: 2019-01-01
Renata Oliveira Pereira, Cynthia Rodrigues Muller, Nilberto Robson Falcão de Nascimento, Manassés Claudino Fonteles, Fabiana Sant'Anna Evangelista, Patricia Fiorino, Vera Farah

The association between hypertension and obesity has been shown to be an important cause of kidney disease. We aimed to investigate the impact of a high-fat diet (HFD) administered in spontaneously hypertensive rats (SHR) after weaning in renal morphology and functional parameters. Male post-weaned SHR were divided into two groups: standard control diet (CD) (3% lipids; n = 8) or HFD (30% lipids; n = 8) during 8 weeks. The group HFD showed an increase in serum triglycerides (HFD: 96 ± 7 vs. CD: 33 ± 2 mg/dL) and glucose intolerance (HFD: 185 ± 7 vs. CD: 149 ± 4 mg/dL/min). Moreover, the HFD also showed an increase in almost 90% of the periepididymal and retroperitoneal adiposity. There was no difference in arterial blood pressure between groups. Renal morphofunctional parameters were decreased in HFD group for glomerular tuft area and diameter (4733 ± 65 µm2 and 82 ± 1 µm, respectively) when compared with CD group (5289 ± 171 µm2 and 88 ± 2 µm, respectively). HFD also showed a decrease of 50% of the renal function, which was associated with higher renal extracellular matrix and lipid deposition. Therefore, our data suggest that HFD since early period of life may contribute to renal damage in adults with hypertension, and this impairment can be associated with increased renal lipid accumulation.

高血压和肥胖之间的关系已被证明是肾脏疾病的一个重要原因。本研究旨在探讨自发性高血压大鼠(SHR)断奶后高脂肪饮食(HFD)对肾脏形态和功能参数的影响。雄性断奶后SHR分为两组:标准对照日粮(CD)(3%脂质;n = 8)或HFD(30%脂质;N = 8), 8周。HFD组显示血清甘油三酯(HFD: 96±7 vs. CD: 33±2 mg/dL)和葡萄糖耐受不良(HFD: 185±7 vs. CD: 149±4 mg/dL/min)增加。此外,HFD也显示近90%的附睾周围和腹膜后脂肪增加。两组之间的动脉血压没有差异。与CD组(5289±171µm2和88±2µm)相比,HFD组肾小球簇面积和直径(分别为4733±65µm2和82±1µm)均降低。HFD还显示肾功能下降50%,这与肾脏细胞外基质和脂质沉积升高有关。因此,我们的数据表明,早期的HFD可能会导致成年高血压患者的肾损害,而这种损害可能与肾脂质积累增加有关。
{"title":"Early consumption of high-fat diet worsens renal damage in spontaneously hypertensive rats in adulthood.","authors":"Renata Oliveira Pereira,&nbsp;Cynthia Rodrigues Muller,&nbsp;Nilberto Robson Falcão de Nascimento,&nbsp;Manassés Claudino Fonteles,&nbsp;Fabiana Sant'Anna Evangelista,&nbsp;Patricia Fiorino,&nbsp;Vera Farah","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The association between hypertension and obesity has been shown to be an important cause of kidney disease. We aimed to investigate the impact of a high-fat diet (HFD) administered in spontaneously hypertensive rats (SHR) after weaning in renal morphology and functional parameters. Male post-weaned SHR were divided into two groups: standard control diet (CD) (3% lipids; n = 8) or HFD (30% lipids; n = 8) during 8 weeks. The group HFD showed an increase in serum triglycerides (HFD: 96 ± 7 vs. CD: 33 ± 2 mg/dL) and glucose intolerance (HFD: 185 ± 7 vs. CD: 149 ± 4 mg/dL/min). Moreover, the HFD also showed an increase in almost 90% of the periepididymal and retroperitoneal adiposity. There was no difference in arterial blood pressure between groups. Renal morphofunctional parameters were decreased in HFD group for glomerular tuft area and diameter (4733 ± 65 µm<sup>2</sup> and 82 ± 1 µm, respectively) when compared with CD group (5289 ± 171 µm<sup>2</sup> and 88 ± 2 µm, respectively). HFD also showed a decrease of 50% of the renal function, which was associated with higher renal extracellular matrix and lipid deposition. Therefore, our data suggest that HFD since early period of life may contribute to renal damage in adults with hypertension, and this impairment can be associated with increased renal lipid accumulation.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"11 6","pages":"258-266"},"PeriodicalIF":0.0,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971500/pdf/ijppp0011-0258.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37587472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How is the association between urinary prostate cancer antigen 3 (PCA3) levels and Gleason scores in patients suspicious of prostate cancer? 可疑前列腺癌患者尿前列腺癌抗原3 (PCA3)水平与Gleason评分的关系如何?
Pub Date : 2019-12-15 eCollection Date: 2019-01-01
Sasan Gilani, Mina Shakery, Pouria Shoureshi, Hojjat Salimi, Hadi Maleki, Ali Alavi, Farinaz Khodadadi

Introduction: Prostate cancer is one of the most common cancers in men which is mostly slow growing and responses well to treatments if early diagnosed. Urinary prostate cancer antigen 3 (PCA3) assay is a new method with effective results in diagnosing prostate cancer. The aim of this present study was evaluate the correlation between urinary PCA3 and Gleason scores in patients who are suspicious of prostate cancer and undergo tissue biopsies.

Methods: This is a cross-sectional study which was performed in 2017-2018. The patients included this study complain of prostate problems and were selected from Nour hospital, Ali-Asghar hospital and Ordibehesht clinic in Tehran, Iran. Urinary PCA3 levels were checked in all patients and then they went under prostate biopsies. Amounts of PCA3 and Gleason scores were collected and analyzed using SPSS software.

Findings: We evaluated a total number of 80 patients. 40 patients had prostate cancer and 40 had no cancer. We indicated that no significant relation was reported between Gleason scores and urinary PCA3 levels. Levels of urinary PCA3 were higher in patients with prostate cancer than in patients with no cancer (P=0.007).

Discussion: Generally, urinary PCA3 test is indicated as a non-invasive method to improve the specificity of prostate cancer diagnosis and its potential predictive value was studied in numerous clinical researches, but here we found higher PCA3 levels in patients with prostate cancer than in patients with and other prostate problems. We conclude that PCA3 functions as a diagnostic test and its changes in prostate cancer need to be further studied in different populations and races.

简介:前列腺癌是男性最常见的癌症之一,大多生长缓慢,如果早期诊断治疗效果良好。尿前列腺癌抗原3 (PCA3)检测是一种诊断前列腺癌的新方法,具有良好的效果。本研究的目的是评估怀疑前列腺癌并接受组织活检的患者尿PCA3和Gleason评分之间的相关性。方法:本研究为横断面研究,于2017-2018年进行。本研究的患者分别来自伊朗德黑兰的Nour医院、Ali-Asghar医院和Ordibehesht诊所,均有前列腺问题。检查所有患者的尿PCA3水平,然后进行前列腺活检。采集PCA3和Gleason评分,采用SPSS软件进行统计分析。结果:我们共评估了80例患者。40名患者患有前列腺癌,40名没有癌症。我们指出Gleason评分和尿PCA3水平之间没有明显的关系。前列腺癌患者尿PCA3水平高于非前列腺癌患者(P=0.007)。讨论:尿PCA3检测通常被认为是一种非侵入性的方法,可以提高前列腺癌诊断的特异性,临床研究大量研究了其潜在的预测价值,但我们发现前列腺癌患者的PCA3水平高于其他前列腺疾病患者。我们得出结论,PCA3作为一种诊断测试,其在前列腺癌中的变化需要在不同人群和种族中进一步研究。
{"title":"How is the association between urinary prostate cancer antigen 3 (PCA3) levels and Gleason scores in patients suspicious of prostate cancer?","authors":"Sasan Gilani,&nbsp;Mina Shakery,&nbsp;Pouria Shoureshi,&nbsp;Hojjat Salimi,&nbsp;Hadi Maleki,&nbsp;Ali Alavi,&nbsp;Farinaz Khodadadi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Prostate cancer is one of the most common cancers in men which is mostly slow growing and responses well to treatments if early diagnosed. Urinary prostate cancer antigen 3 (PCA3) assay is a new method with effective results in diagnosing prostate cancer. The aim of this present study was evaluate the correlation between urinary PCA3 and Gleason scores in patients who are suspicious of prostate cancer and undergo tissue biopsies.</p><p><strong>Methods: </strong>This is a cross-sectional study which was performed in 2017-2018. The patients included this study complain of prostate problems and were selected from Nour hospital, Ali-Asghar hospital and Ordibehesht clinic in Tehran, Iran. Urinary PCA3 levels were checked in all patients and then they went under prostate biopsies. Amounts of PCA3 and Gleason scores were collected and analyzed using SPSS software.</p><p><strong>Findings: </strong>We evaluated a total number of 80 patients. 40 patients had prostate cancer and 40 had no cancer. We indicated that no significant relation was reported between Gleason scores and urinary PCA3 levels. Levels of urinary PCA3 were higher in patients with prostate cancer than in patients with no cancer (P=0.007).</p><p><strong>Discussion: </strong>Generally, urinary PCA3 test is indicated as a non-invasive method to improve the specificity of prostate cancer diagnosis and its potential predictive value was studied in numerous clinical researches, but here we found higher PCA3 levels in patients with prostate cancer than in patients with and other prostate problems. We conclude that PCA3 functions as a diagnostic test and its changes in prostate cancer need to be further studied in different populations and races.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"11 6","pages":"283-288"},"PeriodicalIF":0.0,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971503/pdf/ijppp0011-0283.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37587476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypoglycaemic and anti-diabetic activity of selected African medicinal plants. 某些非洲药用植物的降糖和抗糖尿病活性。
Pub Date : 2019-12-15 eCollection Date: 2019-01-01
Oluwafemi Omoniyi Oguntibeju

The use of medicinal plants in the treatment and management of diabetes mellitus is not very popular in Europe and USA as it is in Africa due to adequate availability of synthetic drugs and insulin for the effective management of diabetes in the western countries. In Africa, over 80% of the population live in poor resource settings and depend on medicinal plants for the treatment of various diseases including diabetes mellitus. Africa is very rich in medicinal plants and many of these plants are used in the treatment of diabetes mellitus. These plants play important role as alternative medicine due to their low cost, perception of their minimal side-effects, availability and knowledge about their use in the treatment of diseases. Many African medicinal plants have been reported to possess pancreatic beta cells regenerating insulin potential, hypoglycaemic effects, increase insulin secretion, enhance glucose uptake by adipose tissue or muscles and inhibit glucose absorption from the intestine and glucose production from the liver. Medicinal plants may potentially provide useful source of new oral hypoglycaemic agents for drug development in pharmaceutical application or as adjuncts for existing therapies in the management of diabetes. This review therefore focuses on selected African medicinal plants with hypoglycaemic and anti-diabetic activities that are used in traditional medicine in the treatment and management of diabetes mellitus. There is an urgent need to document the knowledge of medicinal plants that are used mainly in the treatment and management of diabetes mellitus in various parts of Africa.

在治疗和管理糖尿病方面,药用植物的使用在欧洲和美国并不像在非洲那样流行,因为西方国家有足够的合成药物和胰岛素来有效地管理糖尿病。在非洲,80%以上的人口生活在资源贫乏的环境中,依靠药用植物治疗包括糖尿病在内的各种疾病。非洲有非常丰富的药用植物,其中许多植物被用于治疗糖尿病。这些植物作为替代药物发挥着重要作用,因为它们的成本低、副作用小、可获得性和在治疗疾病方面的知识。据报道,许多非洲药用植物具有胰腺β细胞再生胰岛素潜能、降糖作用、增加胰岛素分泌、增强脂肪组织或肌肉对葡萄糖的摄取、抑制肠道对葡萄糖的吸收和肝脏对葡萄糖的产生。药用植物可作为新型口服降糖药的有效来源,用于药物开发或作为现有糖尿病治疗的辅助手段。因此,本文综述了一些具有降血糖和抗糖尿病活性的非洲药用植物,这些植物在传统医学中用于糖尿病的治疗和管理。迫切需要记录非洲各地主要用于治疗和管理糖尿病的药用植物的知识。
{"title":"Hypoglycaemic and anti-diabetic activity of selected African medicinal plants.","authors":"Oluwafemi Omoniyi Oguntibeju","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The use of medicinal plants in the treatment and management of diabetes mellitus is not very popular in Europe and USA as it is in Africa due to adequate availability of synthetic drugs and insulin for the effective management of diabetes in the western countries. In Africa, over 80% of the population live in poor resource settings and depend on medicinal plants for the treatment of various diseases including diabetes mellitus. Africa is very rich in medicinal plants and many of these plants are used in the treatment of diabetes mellitus. These plants play important role as alternative medicine due to their low cost, perception of their minimal side-effects, availability and knowledge about their use in the treatment of diseases. Many African medicinal plants have been reported to possess pancreatic beta cells regenerating insulin potential, hypoglycaemic effects, increase insulin secretion, enhance glucose uptake by adipose tissue or muscles and inhibit glucose absorption from the intestine and glucose production from the liver. Medicinal plants may potentially provide useful source of new oral hypoglycaemic agents for drug development in pharmaceutical application or as adjuncts for existing therapies in the management of diabetes. This review therefore focuses on selected African medicinal plants with hypoglycaemic and anti-diabetic activities that are used in traditional medicine in the treatment and management of diabetes mellitus. There is an urgent need to document the knowledge of medicinal plants that are used mainly in the treatment and management of diabetes mellitus in various parts of Africa.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"11 6","pages":"224-237"},"PeriodicalIF":0.0,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971502/pdf/ijppp0011-0224.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37589077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nicotinamide phosphoribosyltransferase contributes to cocaine addiction through sirtuin 1. 烟酰胺磷酸核糖基转移酶通过sirtuin 1参与可卡因成瘾。
Pub Date : 2019-12-15 eCollection Date: 2019-01-01
Som Singh, Matthew William, Xiang-Ping Chu

Drug addiction is a persistent mental illness and there is no effective treatment. The precise mechanisms underlying addictive responses have not been completely understood, although ion channels, neurotransmitters as well as their receptors, and intracellular endogenous molecules in the brain have been shown to play important roles in cocaine addiction. Nicotinamide phosphoribosyltransferase (NAMPT) is an important rate-limiting enzyme found throughout the body that converts the intracellular pool of nicotinamide adenine dinucleotide (NAD) into nicotinamide mononucleotide (NMN). It reveals a critical role in physiological and pathophysiological conditions such as NAD biosynthesis, aging, inflammation, obesity, diabetes, stroke, motor dysfunction, and cancer. A recent study published in Experimental Neurology by Cen group demonstrated that NAMPT contributes to cocaine reward through sirtuin 1 (SIRT1) signaling in the brain ventral tegmental area. Thus, targeting NAMPT/SIRT1 signaling pathway may provide a promising therapeutic strategy against cocaine addiction.

药物成瘾是一种持续性的精神疾病,没有有效的治疗方法。尽管离子通道、神经递质及其受体和大脑细胞内内源性分子已被证明在可卡因成瘾中起重要作用,但成瘾反应的确切机制尚不完全清楚。烟酰胺磷酸核糖基转移酶(NAMPT)是一种重要的限速酶,可将细胞内的烟酰胺腺嘌呤二核苷酸(NAD)转化为烟酰胺单核苷酸(NMN)。它揭示了生理和病理生理条件的关键作用,如NAD生物合成、衰老、炎症、肥胖、糖尿病、中风、运动功能障碍和癌症。Cen小组最近发表在《实验神经病学》上的一项研究表明,NAMPT通过大脑腹侧被盖区SIRT1信号传导促进可卡因奖励。因此,靶向NAMPT/SIRT1信号通路可能为可卡因成瘾提供一种有希望的治疗策略。
{"title":"Nicotinamide phosphoribosyltransferase contributes to cocaine addiction through sirtuin 1.","authors":"Som Singh, Matthew William, Xiang-Ping Chu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Drug addiction is a persistent mental illness and there is no effective treatment. The precise mechanisms underlying addictive responses have not been completely understood, although ion channels, neurotransmitters as well as their receptors, and intracellular endogenous molecules in the brain have been shown to play important roles in cocaine addiction. Nicotinamide phosphoribosyltransferase (NAMPT) is an important rate-limiting enzyme found throughout the body that converts the intracellular pool of nicotinamide adenine dinucleotide (NAD) into nicotinamide mononucleotide (NMN). It reveals a critical role in physiological and pathophysiological conditions such as NAD biosynthesis, aging, inflammation, obesity, diabetes, stroke, motor dysfunction, and cancer. A recent study published in Experimental Neurology by Cen group demonstrated that NAMPT contributes to cocaine reward through sirtuin 1 (SIRT1) signaling in the brain ventral tegmental area. Thus, targeting NAMPT/SIRT1 signaling pathway may provide a promising therapeutic strategy against cocaine addiction.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"11 6","pages":"318-320"},"PeriodicalIF":0.0,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971506/pdf/ijppp0011-0318.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37586915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How does the brain remove its waste metabolites from within? 大脑是如何从内部清除废物代谢物的?
Pub Date : 2019-12-15 eCollection Date: 2019-01-01
Yiming Cheng, James Haorah

The brain is the command center of the body that regulates the vital functions of circulation, respiration, motor function, metabolic activities, or autonomic nervous system outcomes. The brain coordinates these continuous activities at the expense of huge energy utilization. This energy demand is achieved by active transport of nutrients across the endothelial blood-brain barrier (BBB). This review discusses the barrier interfaces in the CNS that include the BBB, blood-spinal cord barrier, the epithelial choroid plexus, and the epithelial arachnoid. While transporting of nutrients across the BBB is a normal physiological function, the trafficking of xenobiotics and inflammatory cells/agents across these interfaces is harmful to brain cells. This leads to production of waste metabolites in the brain. Clearance of these waste metabolites maintains the normal brain homeostasis, while aggregation is detrimental to neurological complications. Since the CNS lacks lymphatic system, the CSF serves as the clearance path for water-soluble peptides/solutes, but not large size waste metabolites like Aβ protein. In particular, this review will focus on the mechanisms of waste metabolites clearance paths in the CNS. This will include the recently discovered waste metabolites movement from interstitial space (IS) directly into perivascular clearance (PVC), or via IS-CSF-PVC, and its exchange from PVC to circulation. Concluding remarks will discuss the therapeutic approach to improve the clearance mechanisms for ameliorating neurological diseases.

大脑是身体的指挥中心,调节循环、呼吸、运动功能、代谢活动或自主神经系统的结果等重要功能。大脑以消耗大量能量为代价来协调这些连续的活动。这种能量需求是通过营养物质通过内皮血脑屏障(BBB)的主动运输来实现的。本文综述了中枢神经系统中的屏障界面,包括血脑屏障、血脊髓屏障、上皮性脉络丛和上皮性蛛网膜。虽然营养物质在血脑屏障之间的运输是一种正常的生理功能,但通过这些界面运输外源生物和炎症细胞/因子对脑细胞是有害的。这会导致大脑产生废物代谢物。这些废代谢物的清除维持了正常的脑内平衡,而其聚集对神经系统并发症是有害的。由于中枢神经系统缺乏淋巴系统,脑脊液作为水溶性肽/溶质的清除途径,而不是像Aβ蛋白这样的大尺寸废物代谢物。本文将重点介绍废物代谢物在中枢神经系统中清除途径的机制。这将包括最近发现的废物代谢物从间隙(IS)直接进入血管周围间隙(PVC),或通过IS- csf -PVC,以及其从PVC到循环的交换。结束语将讨论改善神经系统疾病的清除机制的治疗方法。
{"title":"How does the brain remove its waste metabolites from within?","authors":"Yiming Cheng,&nbsp;James Haorah","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The brain is the command center of the body that regulates the vital functions of circulation, respiration, motor function, metabolic activities, or autonomic nervous system outcomes. The brain coordinates these continuous activities at the expense of huge energy utilization. This energy demand is achieved by active transport of nutrients across the endothelial blood-brain barrier (BBB). This review discusses the barrier interfaces in the CNS that include the BBB, blood-spinal cord barrier, the epithelial choroid plexus, and the epithelial arachnoid. While transporting of nutrients across the BBB is a normal physiological function, the trafficking of xenobiotics and inflammatory cells/agents across these interfaces is harmful to brain cells. This leads to production of waste metabolites in the brain. Clearance of these waste metabolites maintains the normal brain homeostasis, while aggregation is detrimental to neurological complications. Since the CNS lacks lymphatic system, the CSF serves as the clearance path for water-soluble peptides/solutes, but not large size waste metabolites like Aβ protein. In particular, this review will focus on the mechanisms of waste metabolites clearance paths in the CNS. This will include the recently discovered waste metabolites movement from interstitial space (IS) directly into perivascular clearance (PVC), or via IS-CSF-PVC, and its exchange from PVC to circulation. Concluding remarks will discuss the therapeutic approach to improve the clearance mechanisms for ameliorating neurological diseases.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"11 6","pages":"238-249"},"PeriodicalIF":0.0,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971497/pdf/ijppp0011-0238.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37587471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer. 膀胱癌与非膀胱癌患者尿液中BLCA-4核基质蛋白水平的比较
Pub Date : 2019-12-15 eCollection Date: 2019-01-01
Ali Alavi, Mohammad-Hosein Izadpanahi, Leila Haghshenas, Romina Faridizad, Mohammad-Javad Eslami, Keyvan Ghadimi

Background: The molecular mechanism of bladder cancer is yet not fully understood. Aim of this study was to compare the levels of BLCA-4 nuclear matrix protein in the urine of patients with bladder cancer and non-affected individuals.

Materials and method: The current cross sectional study was conducted on 45 patients with bladder cancer and 45 patients without bladder cancer who were referred to Alzahra Hospital of Isfahan, Iran in 2017. BCLA-4 Urinary Marker was measured in urine of the patients and individuals. Also correlation between the urine levels of BCLA-4 and other variables were evaluated.

Results: The urine levels of BLCA-4 in the patients with bladder cancer was significantly higher than non-bladder cancer group (P<0.001). There was no significant relationship between urine levels of BLCA-4 with tumor stage and size (P>0.05).

Conclusion: The present study indicated that high urine levels of BLCA-4 was presented in patients with bladder cancer and this tumor marker has a high capability for early diagnosis of the disease, which can be used for screening and follow-up of bladder cancer.

背景:膀胱癌的分子机制尚不完全清楚。本研究的目的是比较膀胱癌患者和未受影响个体尿液中BLCA-4核基质蛋白的水平。材料与方法:本横断面研究选取2017年转诊至伊朗伊斯法罕Alzahra医院的45例膀胱癌患者和45例非膀胱癌患者。测定患者和个体尿液中BCLA-4尿标记物。同时评估尿BCLA-4水平与其他变量的相关性。结果:膀胱癌患者尿液中BLCA-4水平显著高于非膀胱癌组(P0.05)。结论:本研究提示膀胱癌患者尿液中存在高水平的BLCA-4,该肿瘤标志物对膀胱癌具有较高的早期诊断能力,可用于膀胱癌的筛查和随访。
{"title":"Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer.","authors":"Ali Alavi,&nbsp;Mohammad-Hosein Izadpanahi,&nbsp;Leila Haghshenas,&nbsp;Romina Faridizad,&nbsp;Mohammad-Javad Eslami,&nbsp;Keyvan Ghadimi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The molecular mechanism of bladder cancer is yet not fully understood. Aim of this study was to compare the levels of BLCA-4 nuclear matrix protein in the urine of patients with bladder cancer and non-affected individuals.</p><p><strong>Materials and method: </strong>The current cross sectional study was conducted on 45 patients with bladder cancer and 45 patients without bladder cancer who were referred to Alzahra Hospital of Isfahan, Iran in 2017. BCLA-4 Urinary Marker was measured in urine of the patients and individuals. Also correlation between the urine levels of BCLA-4 and other variables were evaluated.</p><p><strong>Results: </strong>The urine levels of BLCA-4 in the patients with bladder cancer was significantly higher than non-bladder cancer group (P<0.001). There was no significant relationship between urine levels of BLCA-4 with tumor stage and size (P>0.05).</p><p><strong>Conclusion: </strong>The present study indicated that high urine levels of BLCA-4 was presented in patients with bladder cancer and this tumor marker has a high capability for early diagnosis of the disease, which can be used for screening and follow-up of bladder cancer.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"11 6","pages":"289-292"},"PeriodicalIF":0.0,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971499/pdf/ijppp0011-0289.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37587477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes retinopathy and related health management in Asians versus whites using BRFSS 2005-2017 data. 亚洲人与白人糖尿病视网膜病变及相关健康管理的BRFSS 2005-2017数据
Pub Date : 2019-12-15 eCollection Date: 2019-01-01
Fengxia Yan, Jianfei Guo, Robert Mayberry, Qingwei Luo, Yonggang Li, Gengsheng Qin

Purpose: Asian Americans had high rate of type 2 diabetes and less risk for diabetes complications compared to white. The purpose of this study was to examine diabetic retinopathy and related healthcare management among Asian American adults with diabetes.

Materials and method: Asian and white type 2 diabetes participants from 2005-2017 Behavioral Risk Factor Surveillance System (BRFSS) data were used to perform the analysis. SAS 9.4 survey procedures were used to conduct the statistical test. Health care management variables (self-blood sugar check, eye check and HbA1C check with doctors, health care professional visit) were analyzed and compared between Asian and white.

Results: During 2005-2017, diabetic retinopathy (DR) rate among Asian Americans was 10% higher than white, and Asian Americans was more than 100% more likely to develop DR compared to white. Asian Americans was less likely to check their blood sugar once a day (P<0.05 for all years except 2005 and 2007) and more likely to see the health care professional and perform eye and HbA1C check even the relationship was not statistically significant. After adjusting all the demo-social factors and health care management factors, Asian still had higher rate of DR compared to white.

Conclusion: Asian Americans had higher rate of DR rate compared to white. Asian and white all had low rate of selfcare of blood sugar. Interventions for DR need to apply among Asian population.

目的:与白人相比,亚裔美国人2型糖尿病发病率高,糖尿病并发症风险低。本研究的目的是探讨亚裔美国成人糖尿病患者的糖尿病视网膜病变和相关的保健管理。材料和方法:使用2005-2017年行为风险因素监测系统(BRFSS)数据中的亚洲和白人2型糖尿病参与者进行分析。采用SAS 9.4调查程序进行统计检验。对亚裔和白人的健康管理变量(自我血糖检查、眼科检查和医生检查HbA1C、保健专业人员就诊)进行分析比较。结果:2005-2017年,亚裔美国人的糖尿病视网膜病变(DR)发生率比白人高10%,亚裔美国人患DR的可能性比白人高100%以上。亚裔美国人每天检查一次血糖的可能性较低(结论:亚裔美国人的DR率高于白人。亚裔和白人的血糖自我护理率均较低。针对DR的干预措施需要适用于亚洲人群。
{"title":"Diabetes retinopathy and related health management in Asians versus whites using BRFSS 2005-2017 data.","authors":"Fengxia Yan,&nbsp;Jianfei Guo,&nbsp;Robert Mayberry,&nbsp;Qingwei Luo,&nbsp;Yonggang Li,&nbsp;Gengsheng Qin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Asian Americans had high rate of type 2 diabetes and less risk for diabetes complications compared to white. The purpose of this study was to examine diabetic retinopathy and related healthcare management among Asian American adults with diabetes.</p><p><strong>Materials and method: </strong>Asian and white type 2 diabetes participants from 2005-2017 Behavioral Risk Factor Surveillance System (BRFSS) data were used to perform the analysis. SAS 9.4 survey procedures were used to conduct the statistical test. Health care management variables (self-blood sugar check, eye check and HbA1C check with doctors, health care professional visit) were analyzed and compared between Asian and white.</p><p><strong>Results: </strong>During 2005-2017, diabetic retinopathy (DR) rate among Asian Americans was 10% higher than white, and Asian Americans was more than 100% more likely to develop DR compared to white. Asian Americans was less likely to check their blood sugar once a day (P<0.05 for all years except 2005 and 2007) and more likely to see the health care professional and perform eye and HbA1C check even the relationship was not statistically significant. After adjusting all the demo-social factors and health care management factors, Asian still had higher rate of DR compared to white.</p><p><strong>Conclusion: </strong>Asian Americans had higher rate of DR rate compared to white. Asian and white all had low rate of selfcare of blood sugar. Interventions for DR need to apply among Asian population.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"11 6","pages":"310-317"},"PeriodicalIF":0.0,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971498/pdf/ijppp0011-0310.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37586914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nephroprotective effect of Costus afer on lead induced kidney damage in albino rats. 木香对铅致白化大鼠肾损伤的保护作用。
Pub Date : 2019-04-15 eCollection Date: 2019-01-01
Anthonet Ndidiamaka Ezejiofor, Orish Ebere Orisakwe

Background: Lead is a nephrotoxicant probably implicated in the rising incidence of chronic kidney injury in sub-Sahara Africa. With the prohibitive cost and unavailability of metal chelators, chronic kidney disease CKD prevention is very difficult hence the search for affordable alternative. Costus afer have been shown to be organo-protective. The present research investigated the nephroprotective effect of aqueous leaf extract of Costus afer on lead induced nephrotoxicity in male rats.

Methods: Adult male rats were weight matched into five groups of five rats each. Groups 1 & 2 serve as normal and toxic control receiving deionized and leaded (CH3COO)2Pb. 3H2O water respectively. Groups 3, 4 and 5 were administered peroral 750, 1500 and 2250 mg/kg of aqueous leaf extract of Costus afer respectively while receiving Pb2+ water ad libitum. Hematological, antioxidant and histological parameters obtained from the result serve as scientific evidence in the study.

Results: Costus afer treatment significantly reversed (P < 0.05) the decrease in the levels of gluthatione peroxidase (GSH-PX), superoxide dismutase (SOD), catalase (CAT), Glutathione-S-trasferase activity (GST) seen in the lead acetate only treated group. Similarly, the increased malondialdehyde (MDA) level in the lead acetate only treated group was significantly (P < 0.05) reduced in the Costus afer treated groups. There were significant (P < 0.05) decreases in serum serum level of sodium (146 ± 2.1 to 133 ± 6.0) and potassium (5.1 ± 0.4 to 4.4 ± 0.3) in lead acetate alone and treated group respectively. Also recorded was a significant (P < 0.05) decrease in serum levels of total protein and albumin (67 ± 7.9 to 47 ± 5.0 g/dl) and (45 ± 4.4 to 33 ± 5.5 g/dl) in lead acetate alone and Costus afer treated groups respectively.

Conclusions: Aqueous leaf extract of Costus afer may be nephroprotective in albino rats.

背景:铅是一种肾毒性物质,可能与撒哈拉以南非洲地区慢性肾损伤发生率上升有关。由于金属螯合剂的高昂成本和不可获得性,慢性肾脏疾病CKD的预防非常困难,因此寻找负担得起的替代品。木香已被证明对器官有保护作用。本研究探讨木香叶水提物对铅致雄性大鼠肾毒性的保护作用。方法:将成年雄性大鼠体重匹配成5组,每组5只。第1组和第2组作为正常对照和毒性对照,分别接受去离子化和铅化(CH3COO)2Pb。分别是3H2O水。3组、4组和5组小鼠分别口服木香叶水提物750、1500和2250 mg/kg,并随意饮水。结果得到的血液学、抗氧化和组织学参数为研究提供了科学依据。结果:木香处理后显著逆转了仅醋酸铅处理组的谷胱甘肽过氧化物酶(GSH-PX)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽- s -转移酶活性(GST)的下降(P < 0.05)。同样,仅醋酸铅处理组升高的丙二醛(MDA)水平在处理后各组木螺中显著降低(P < 0.05)。血清钠(146±2.1 ~ 133±6.0)、钾(5.1±0.4 ~ 4.4±0.3)水平分别显著(P < 0.05)降低。血清总蛋白和白蛋白水平分别降低(67±7.9 ~ 47±5.0 g/dl)和(45±4.4 ~ 33±5.5 g/dl) (P < 0.05)。结论:木香叶水提物对白化大鼠肾脏有保护作用。
{"title":"Nephroprotective effect of <i>Costus afer</i> on lead induced kidney damage in albino rats.","authors":"Anthonet Ndidiamaka Ezejiofor,&nbsp;Orish Ebere Orisakwe","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Lead is a nephrotoxicant probably implicated in the rising incidence of chronic kidney injury in sub-Sahara Africa. With the prohibitive cost and unavailability of metal chelators, chronic kidney disease CKD prevention is very difficult hence the search for affordable alternative. <i>Costus afer</i> have been shown to be organo-protective. The present research investigated the nephroprotective effect of aqueous leaf extract of <i>Costus afer</i> on lead induced nephrotoxicity in male rats.</p><p><strong>Methods: </strong>Adult male rats were weight matched into five groups of five rats each. Groups 1 & 2 serve as normal and toxic control receiving deionized and leaded (CH<sub>3</sub>COO)<sub>2</sub>Pb. 3H<sub>2</sub>O water respectively. Groups 3, 4 and 5 were administered peroral 750, 1500 and 2250 mg/kg of aqueous leaf extract of <i>Costus afer</i> respectively while receiving Pb<sup>2+</sup> water <i>ad libitum</i>. Hematological, antioxidant and histological parameters obtained from the result serve as scientific evidence in the study.</p><p><strong>Results: </strong><i>Costus afer</i> treatment significantly reversed (P < 0.05) the decrease in the levels of gluthatione peroxidase (GSH-PX), superoxide dismutase (SOD), catalase (CAT), Glutathione-S-trasferase activity (GST) seen in the lead acetate only treated group. Similarly, the increased malondialdehyde (MDA) level in the lead acetate only treated group was significantly (P < 0.05) reduced in the <i>Costus afer</i> treated groups. There were significant (P < 0.05) decreases in serum serum level of sodium (146 ± 2.1 to 133 ± 6.0) and potassium (5.1 ± 0.4 to 4.4 ± 0.3) in lead acetate alone and treated group respectively. Also recorded was a significant (P < 0.05) decrease in serum levels of total protein and albumin (67 ± 7.9 to 47 ± 5.0 g/dl) and (45 ± 4.4 to 33 ± 5.5 g/dl) in lead acetate alone and <i>Costus afer</i> treated groups respectively.</p><p><strong>Conclusions: </strong>Aqueous leaf extract of <i>Costus afer</i> may be nephroprotective in albino rats.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":" ","pages":"36-44"},"PeriodicalIF":0.0,"publicationDate":"2019-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526387/pdf/ijppp0011-0036.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37289509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The rise of circulatory endothelin (ET)-1 and endothelin receptors (ETA, ETB) expression in kidney of obese wistar rat. 肥胖wistar大鼠肾脏循环内皮素(ET)-1和内皮素受体(ETA、ETB)表达的升高。
Pub Date : 2019-04-15 eCollection Date: 2019-01-01
Irfan Idris, Andi Wardihan Sinrang, Aryadi Arsyad, Syafrudin Alwi, Muhammad Isman Sandira

Background: Endothelin (ET)-1, a circulatory protein, and its receptors (ETA and ETB) in various organs were reported to play a pivotal role in many diseases, including obesity. However, the changes of ETA and ETB expression in ventricle and kidney in obesity was less reported. The study is designed to observe the level of circulatory ET-1 and expression of ETA/ETB in ventricle and kidney of obese, as compared to non-obese, Wistar rats.

Methods: Groups of obese 14 and 34 weeks Wistar rats were compared to non-obese controls at similar ages. The obesity status was achieved by feeding the with high calories protein diet CP 551 + milk powder, while the control group was fed with a standard calorie protein AD II diet. The concentration of circulatory ET-1, ETA and ETB of ventricle and kidney were measured by Enzyme Linked Immunosorbent Assay (ELISA) technique after the termination of both groups at 14th and 24th weeks.

Results: The level of circulatory ET-1, expression of ETA and ETB in kidney, and LDL of obese rats were significantly higher than control rats (T-Test, P<0.05) in the elder groups, while no differences of the ETA and ETB were found in the ventricle. No differences of the levels of circulatory ET-1, ETA and ETB expression were found between obese and control groups of younger rats (P>0.05). HDL levels were under normal value for both groups.

Conclusion: Obesity in elder obese rats leads to dysregulation of kidney vessels through activity of ET-1 and ETA/ETB.

背景:据报道,内皮素(ET)-1 是一种循环蛋白,其在不同器官中的受体(ETA 和 ETB)在包括肥胖症在内的多种疾病中起着关键作用。然而,有关肥胖症患者心室和肾脏中 ETA 和 ETB 表达变化的报道较少。本研究旨在观察与非肥胖 Wistar 大鼠相比,肥胖大鼠心室和肾脏中循环 ET-1 的水平以及 ETA/ETB 的表达:方法:将 14 周和 34 周肥胖 Wistar 大鼠组与年龄相仿的非肥胖对照组进行比较。肥胖组采用高热量蛋白质饮食 CP 551 + 奶粉,对照组采用标准热量蛋白质饮食 AD II。两组分别在第14周和第24周终止实验后,采用酶联免疫吸附试验(ELISA)技术测定心室和肾脏循环中ET-1、ETA和ETB的浓度:结果:肥胖大鼠循环中 ET-1 的水平、肾脏中 ETA 和 ETB 的表达以及低密度脂蛋白均显著高于对照组(T 检验),心室中发现 PA 和 ETB。肥胖组和对照组年轻大鼠循环中的 ET-1、ETA 和 ETB 表达水平无差异(P>0.05)。两组大鼠的高密度脂蛋白水平均低于正常值:结论:老年肥胖大鼠的肥胖会通过 ET-1 和 ETA/ETB 的活性导致肾脏血管失调。
{"title":"The rise of circulatory endothelin (ET)-1 and endothelin receptors (ET<sub>A</sub>, ET<sub>B</sub>) expression in kidney of obese wistar rat.","authors":"Irfan Idris, Andi Wardihan Sinrang, Aryadi Arsyad, Syafrudin Alwi, Muhammad Isman Sandira","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Endothelin (ET)-1, a circulatory protein, and its receptors (ET<sub>A</sub> and ET<sub>B</sub>) in various organs were reported to play a pivotal role in many diseases, including obesity. However, the changes of ET<sub>A</sub> and ET<sub>B</sub> expression in ventricle and kidney in obesity was less reported. The study is designed to observe the level of circulatory ET-1 and expression of ET<sub>A</sub>/ET<sub>B</sub> in ventricle and kidney of obese, as compared to non-obese, <i>Wistar</i> rats.</p><p><strong>Methods: </strong>Groups of obese 14 and 34 weeks <i>Wistar</i> rats were compared to non-obese controls at similar ages. The obesity status was achieved by feeding the with high calories protein diet CP 551 + milk powder, while the control group was fed with a standard calorie protein AD II diet. The concentration of circulatory ET-1, ET<sub>A</sub> and ET<sub>B</sub> of ventricle and kidney were measured by Enzyme Linked Immunosorbent Assay (ELISA) technique after the termination of both groups at 14<sup>th</sup> and 24<sup>th</sup> weeks.</p><p><strong>Results: </strong>The level of circulatory ET-1, expression of ET<sub>A</sub> and ET<sub>B</sub> in kidney, and LDL of obese rats were significantly higher than control rats (T-Test, P<0.05) in the elder groups, while no differences of the ET<sub>A</sub> and ET<sub>B</sub> were found in the ventricle. No differences of the levels of circulatory ET-1, ET<sub>A</sub> and ET<sub>B</sub> expression were found between obese and control groups of younger rats (P>0.05). HDL levels were under normal value for both groups.</p><p><strong>Conclusion: </strong>Obesity in elder obese rats leads to dysregulation of kidney vessels through activity of ET-1 and ET<sub>A</sub>/ET<sub>B</sub>.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":" ","pages":"31-35"},"PeriodicalIF":0.0,"publicationDate":"2019-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526386/pdf/ijppp0011-0031.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37294524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-stroke neuronal circuits and mental illnesses. 中风后的神经回路和精神疾病。
Pub Date : 2019-02-15 eCollection Date: 2019-01-01
Farzaneh Sadat Naghavi, Erin E Koffman, Boren Lin, Jianyang Du

Stroke is one of the leading causes of death in the United States. It is also associated with severe mental illnesses, such as depression and anxiety, that hinder the rehabilitation of surviving patients. Thus, a better understanding of how stroke causes mental illnesses is crucial, but little is known about the neurological mechanisms involved. In this review, we summarized the most common mental illnesses developed after stroke, as well as the underlying mechanisms at the neuronal circuit level.

中风是美国人死亡的主要原因之一。它还与严重的精神疾病有关,如抑郁症和焦虑症,这些疾病阻碍了幸存患者的康复。因此,更好地了解中风如何导致精神疾病是至关重要的,但对其中涉及的神经机制知之甚少。在这篇综述中,我们总结了中风后最常见的精神疾病,以及在神经元回路水平上的潜在机制。
{"title":"Post-stroke neuronal circuits and mental illnesses.","authors":"Farzaneh Sadat Naghavi,&nbsp;Erin E Koffman,&nbsp;Boren Lin,&nbsp;Jianyang Du","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Stroke is one of the leading causes of death in the United States. It is also associated with severe mental illnesses, such as depression and anxiety, that hinder the rehabilitation of surviving patients. Thus, a better understanding of how stroke causes mental illnesses is crucial, but little is known about the neurological mechanisms involved. In this review, we summarized the most common mental illnesses developed after stroke, as well as the underlying mechanisms at the neuronal circuit level.</p>","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"11 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420715/pdf/ijppp0011-0001.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37090492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of physiology, pathophysiology and pharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1